Literature DB >> 28912092

Comparison of gut microbiota in adult patients with type 2 diabetes and healthy individuals.

Mansour Sedighi1, Shabnam Razavi2, Fatemeh Navab-Moghadam3, Mohammad E Khamseh4, Fariba Alaei-Shahmiri5, Amirhosein Mehrtash6, Nour Amirmozafari7.   

Abstract

Recent studies indicate that inflammatory reactions leading to the development of type 2 diabetes mellitus (T2DM) may also contribute to variations in the composition of the intestinal microbiota, suggesting a relation between T2DM and bacterial residents in the intestinal tract. This case-control study was designed to evaluate the composition of the gut microbiota dominant bacterial groups in patients with T2DM compared to the healthy people. A total of 36 adult subjects (18 patients diagnosed with T2DM and 18 healthy persons) were included in the study. The intestinal microbiota composition was investigated by quantitative real-time polymerase chain reaction (qPCR) method using bacterial 16S rRNA gene. The quantities of two groups of bacteria were meaningfully different among T2DM patients and healthy individuals. While, the level of Lactobacillus was significantly higher in the patients with T2DM (P value < 0.001), Bifidobacterium was significantly more frequent in the healthy people (P value < 0.001). The quantities of Prevotella (P value = 0.0.08) and Fusobacterium (P value = 0.99) genera in faecal samples were not significantly different between the two groups. The significant alterations in dominant faecal bacterial genera found in T2DM patients participating in the current study highlight the link between T2DM disease and compositional variation in intestinal flora. These findings may be valuable for developing approaches to control T2DM by modifying the gut microbiota. More investigations with focus on various taxonomic levels (family, genus and species) of bacteria are necessary to clarify the exact relevance of changes in the gut microbial communities with the progression of T2DM disorder.
Copyright © 2017. Published by Elsevier Ltd.

Entities:  

Keywords:  Bacterial compositions; Gut microbiota; Metabolic syndrome; Real-time PCR; Type 2 diabetes mellitus

Mesh:

Substances:

Year:  2017        PMID: 28912092     DOI: 10.1016/j.micpath.2017.08.038

Source DB:  PubMed          Journal:  Microb Pathog        ISSN: 0882-4010            Impact factor:   3.738


  60 in total

Review 1.  Manipulation of intestinal microbiome as potential treatment for insulin resistance and type 2 diabetes.

Authors:  Yasaman Ghorbani; Katherine J P Schwenger; Johane P Allard
Journal:  Eur J Nutr       Date:  2021-03-02       Impact factor: 5.614

Review 2.  Metabolites Linking the Gut Microbiome with Risk for Type 2 Diabetes.

Authors:  Tiantian Zhu; Mark O Goodarzi
Journal:  Curr Nutr Rep       Date:  2020-06

3.  Developmental Origins of Health and Disease: Impact of environmental dust exposure in modulating microbiome and its association with non-communicable diseases.

Authors:  Delicia Shu-Qin Ooi; Cheryl Pei-Ting Tan; Michelle Jia-Yu Tay; Siong Gim Ong; Elizabeth Huiwen Tham; Kewin Tien Ho Siah; Johan Gunnar Eriksson; Keith M Godfrey; Lynette Pei-Chi Shek; Evelyn Xiu-Ling Loo
Journal:  J Dev Orig Health Dis       Date:  2020-06-15       Impact factor: 2.401

4.  Main gut bacterial composition differs between patients with type 1 and type 2 diabetes and non-diabetic adults.

Authors:  Hanieh-Sadat Ejtahed; Zahra Hoseini-Tavassol; Shohre Khatami; Mehrangiz Zangeneh; Ava Behrouzi; Sara Ahmadi Badi; Arfa Moshiri; Shirin Hasani-Ranjbar; Ahmad-Reza Soroush; Farzam Vaziri; Abolfazl Fateh; Mostafa Ghanei; Saeid Bouzari; Shahin Najar-Peerayeh; Seyed Davar Siadat; Bagher Larijani
Journal:  J Diabetes Metab Disord       Date:  2020-02-08

5.  The landscape of microbiota research in Iran; a bibliometric and network analysis.

Authors:  Hossein Aazami; Hojat DehghanBanadaki; Hanieh-Sadat Ejtahed; Noushin Fahimfar; Farideh Razi; Ahmad-Reza Soroush; Shirin Hasani-Ranjbar; Parvin Pasalar; Sara Ahmadi Badi; Seyed-Davar Siadat; Bagher Larijani
Journal:  J Diabetes Metab Disord       Date:  2020-01-15

Review 6.  New Insights into Stroke Prevention and Treatment: Gut Microbiome.

Authors:  Linna Zhao; Liji Yang; Yuying Guo; Jie Xiao; Junping Zhang; Shixin Xu
Journal:  Cell Mol Neurobiol       Date:  2021-02-26       Impact factor: 5.046

Review 7.  Next Generation Probiotics for Neutralizing Obesogenic Effects: Taxa Culturing Searching Strategies.

Authors:  Ana López-Moreno; Inmaculada Acuña; Alfonso Torres-Sánchez; Ángel Ruiz-Moreno; Klara Cerk; Ana Rivas; Antonio Suárez; Mercedes Monteoliva-Sánchez; Margarita Aguilera
Journal:  Nutrients       Date:  2021-05-12       Impact factor: 5.717

Review 8.  Gut Microbiota: Critical Controller and Intervention Target in Brain Aging and Cognitive Impairment.

Authors:  Hui Li; Junjun Ni; Hong Qing
Journal:  Front Aging Neurosci       Date:  2021-06-25       Impact factor: 5.750

Review 9.  Pathophysiological Characteristics Linking Type 2 Diabetes Mellitus and Colorectal Neoplasia.

Authors:  T Grega; G Vojtechova; M Gregova; M Zavoral; S Suchanek
Journal:  Physiol Res       Date:  2021-06-01       Impact factor: 1.881

10.  Host and gut microbial tryptophan metabolism and type 2 diabetes: an integrative analysis of host genetics, diet, gut microbiome and circulating metabolites in cohort studies.

Authors:  Qibin Qi; Jun Li; Bing Yu; Jee-Young Moon; Jin C Chai; Jordi Merino; Jie Hu; Miguel Ruiz-Canela; Casey Rebholz; Zheng Wang; Mykhaylo Usyk; Guo-Chong Chen; Bianca C Porneala; Wenshuang Wang; Ngoc Quynh Nguyen; Elena V Feofanova; Megan L Grove; Thomas J Wang; Robert E Gerszten; Josée Dupuis; Jordi Salas-Salvadó; Wei Bao; David L Perkins; Martha L Daviglus; Bharat Thyagarajan; Jianwen Cai; Tao Wang; JoAnn E Manson; Miguel A Martínez-González; Elizabeth Selvin; Kathryn M Rexrode; Clary B Clish; Frank B Hu; James B Meigs; Rob Knight; Robert D Burk; Eric Boerwinkle; Robert C Kaplan
Journal:  Gut       Date:  2021-06-14       Impact factor: 31.793

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.